It is our policy;

  • to develop, manufacture and distribute safe and effective intraocular lenses to replace the cataractous lens in a human eye or to enhance or improve the visual acuity of existing pseudophakic patients.
  • to maintain an effective Quality Management System that supports our business goals and our compliance to applicable regulatory requirements and standards – the European Medical Device Directive 93/42 – EEC and also the FDA’s QSR – 21 CFR Part 820.
  • to demonstrate continuous improvement by setting annual quality and operational goals, targets, and objectives.
  • to ensure that customer needs and expectations are determined and fulfilled with the aim of achieving customer satisfaction.
  • to be compliant with all applicable laws and legislation of the countries in which we trade.
  • to be committed to the highest standards of ethical conduct in the execution of our business and to comply with Industry codes of conduct; the ABHI Code of Business Practice and the MedTech Europe Codes on Interactions with Healthcare Professionals.

In furtherance of our compliance objectives we adhere to the following specific policies:

Rayner Intraocular Lenses limited
The Ridley Innovation Centre
10 Dominion Way
West Sussex
BN14 8AQ
United Kingdom